Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Strong buying this morning.

No wonder the buyers are back again!
LONDON (AFX) - Energy Technique PLC, the company behind the Nightingale air filtration unit that kills the MRSA hospital superbug, will address a health commission looking into the superbug crisis.

The company will report that Nightingale has been shown to be 99.8 pct effective by the Health Protection Agency at Porton Down, Wiltshire.

Energy Technique said it is still in talks to sell Nightingale units into the National Health Service.

In July, the company announced its first sale of a Nightingale Unit into a US hospital in Randallstown, Maryland.

newsdesk@afxnews.com

SueHelen hope you are smiling this morning you certainly deserve to be!!

What a call by myself, re : my post about the last 45 minutes of trading yesterday the market makers were looking a bit dodgy on Level 2 as I posted, excellent news out today. I'll be back later after I've had my breakfast.

Some excellent weekend press should be coming this weekend and more good gains should follow suit next week as well.

RNS Number:6878B
Energy Technique PLC
06 August 2004


Nightingale superbug killer in presentation to NHS chiefs

Energy Technique plc, the UK company behind the world-beating Nightingale air
filtration unit that kills the MRSA hospital superbug, is to address a health
Commission looking into the superbug crisis.

The company will tell NHS chiefs and members of the public how Nightingale has
been shown to be 99.8% effective by the Health Protection Agency at Porton Down,
Wiltshire.

The invitation to address the September 1st meeting at Newton Aycliffe, County
Durham, comes as Energy Technique continues discussions to sell Nightingale
units into the National Health Service.

Energy Technique Managing Director Leigh Stimpson said: "This marks a welcome
advance in our efforts to make contact with influential opinion formers and
decision makers within the NHS."

Mr Stimpson added: "We are especially pleased to be able to talk to members of
the public - the growing threat of MRSA in our hospitals is an issue that
affects everybody."

The Newton Aycliffe forum has been organised by the Commission for Patient and
Public Involvement in Health, an independent public body sponsored by the
Department of Health. Its forums - run independently of the DoH, are intended to
bring local needs into policy making agendas.

Energy Technique recently announced its first sale of a Nightingale Unit into a
US hospital in Randallstown, Maryland.

Nightingale uses ultraviolet radiation combined with sophisticated air flow
systems to attack the DNA of killer germs such as MRSA, anthrax and TB. First
unveiled at the end of 2002 following prototype testing, the system has
subsequently undergone further development ahead of extensive commercial
marketing.

For further information contact:

Leigh Stimpson, Managing Director, Energy Technique plc: 020 8783 0033
Duncan McCormick, First City Financial: 020 7436 7486
077 3918 5050


www.energytechniqueplc.co.uk




This information is provided by RNS
The company news service from the London Stock Exchange
END

LONDON (AFX) - Energy Technique PLC, the company behind the Nightingale air
filtration unit that kills the MRSA hospital superbug, will address a health
commission looking into the superbug crisis.
The company will report that Nightingale has been shown to be 99.8 pct
effective by the Health Protection Agency at Porton Down, Wiltshire.
Energy Technique said it is still in talks to sell Nightingale units into
the National Health Service.
In July, the company announced its first sale of a Nightingale Unit into a
US hospital in Randallstown, Maryland.
newsdesk@afxnews.com
jc

LONDON (AFX) - Hopes of a deal with the NHS provided the spur to Energy
Technique.
The company is behind the Nightingale air filtration unit that kills the
MRSA hospital superbug, and will address a health commission looking into the
superbug crisis.
Nightingale has been shown to be 99.8 pct effective by the Health Protection
Agency at Porton Down, Wiltshire.
Energy Technique, whose shares were 1.00 higher at 6.87 pence by 8.26 am,
said it is still in talks to sell Nightingale units into the National Health
Service.

Charts + Indicators, all looking good :



Level 2 currently very strong and the best it can get at 3 v 1.

SueHelen you certainly can pick them good on you, well done.

Dear Santa,
For christmas can I please have a bigger pair of do dahs so I can make lots of dosh like SueHelen.
Fully invested so can't join you on board not untill either gsk,vod,shel,dge come's across and that's not going to happen for a while. The last of it went on HNR.

Mickeyskint by name Mickeyskint by nature.

Good luck

sue helen everything you said is going to happen has happend, award yourself a mbbe for services to this bb

Thanks guys....

Couple of tick ups with the price at 6.75-7.50 pence now. Good buying continues with about 2.6 million in buys and 600,000 in sells reported. There should be lots of mentions in the weekend press leading to buying continuing into Monday.

Sue hows the level 2, Not sure how long they can keep the offer at 7.25p .Buys flooding in. Have 3 trades running at present. Rolled over at 7.2p- 7.25p on T25

Very heavy buying continuing. 2 * Market Maker buys have come through at 7.25 pence. WINS who are one of the market makers have another large buy order to fill. WINS were the ones who filled the 500,000 T (single protected purchase) buy at 7.12 pence earlier.

Level 2 at 1 v 1, 6.75-7.25 pence, further gains are likely on Monday.

Friday's Leaders & Laggards
MoneyAM

Energy Technique were ahead 1.25p (21.2%) on hopes that ongoing talks about an NHS deal for its superbug-beating Nightingale filtration system would be fruitful.

Sue cannot see what choice the NHS have. Here is a product that can help in the fight against MRSA .When Hospitals in the US are all ready starting to take up the product. If the NHS fail to support Nightingale and MRSA continues to kill, they ( NHS ) will find themselves with a PR nightmare, when the general public discover what is going on.

what is the price expectancy on this for 2004

just how many cases of superbug have been contracted from air , not many I would think , most cases from dirty hands , dirty everything else , HCEG has got more going for it.

Agree Mad doc also hold HCEG. Good threads on MW website.But a combination of both approaches will imho eradicate MRSA.At present though ETQ has the momentum behind it and is a 1/6th of the value of HCEG.

True MRSA is a contact bug, but the case for having an isolation ward for infected patients is a must and that environment should be kept as sanitised as is poss. Times are moving forward and I'm sure a few years from now people will think it their right to have clean air, especially inside a hospital and in the workplace. A machine such as this that kills 99% of all airbourne germs dead (just as domestos does the loo) has wider implications / benifits for any purchaser. An outbreak of SARS for example could be controlled more easily with proper facilities like isolation wards.

Yoyo , I agree with your argument but the other 1% can still get you !